Your Service Options - The Entire Proteomics Value Chain in One Company
ions.bio transforms complex research into clear scientific insight by offering a comprehensive, all-in-one solution for clinical proteomics. We design studies, provide biosamples with our clinical experts, and convert these samples into extensive multi-omics datasets. These datasets are rigorously analyzed using our proprietary data processing, bioinformatics, and AI-driven software suite.
Get a free consultationService Categories
-
Biosample Collection
No samples? No problem! We provide a wide range of high-quality biosamples. Whether from our in-house collection or our trusted partner network, we will help you source samples, tailored to your specific research goals.
-
Biomarker Discovery
Cutting-edge mass spectrometry-based multi-omics ensures accurate and reproducible data. Our discovery engine is fueled by proprietary software solutions to optimize data acquisition and knowledge extraction from mass spectrometry data.
-
Biomarker Validation
We transform biomarker candidates into ready-to-use, targeted assays for reliable, high-throughput monitoring. Our team designs custom internal standards for absolute quantification to ensure consistent accuracy. These assays can be thoroughly validated using large-scale cohorts and rigorous quality control.
-
Drug Target Discovery
Our integrated proteomics platform accelerates the identification and validation of novel drug targets by combining deep mass spectrometry expertise with advanced multi-omics analytics. Utilizing proprietary algorithms and curated databases, we systematically uncover actionable targets, supporting the development of innovative therapeutics and enabling more precise intervention strategies in complex diseases.
-
Mechanism of Action (MoA) Studies
We provide comprehensive mechanism of action studies by leveraging high-resolution mass spectrometry and advanced bioinformatics. Our expertise reveals molecular pathways and biological networks affected by candidate drugs, offering clear insights into efficacy and offtarget effects. These studies help refine drug candidates and guide rational design for preclinical and clinical development.
-
Clinical Trial Patient Stratification
We empower pharmaceutical partners by providing crucial support for clinical trials through advanced biomarker discovery and validation. We specialize in developing and delivering high-quality predictive biomarkers, enabling precise patient stratification and enhancing the overall efectiveness of clinical studies. By leveraging our expertise, we help streamline the drug development process, potentially reducing costs and accelerating time-to-market for new therapeutics.
-
Pharmacodynamic Services
We help to identify and establish pharmacodynamic biomarkers through our advanced mass spectrometry platform and our sensitive AI-driven data analysis pipeline. Our in-house database, built from years of experience, aids in validating and selecting the best markers. Partnering with ions.bio accelerates the drug discovery process, enabling informed preclinical and clinical research decisions.
-
Data Analysis
Advanced bioinformatics and statistical analysis generate meaningful insights from complex datasets. Our data analysis leverages years of experience with multi-omics datasets from clinical samples and our extensive proprietary database.
Why ions.bio
Position as the solution to reduce time-consuming and risky to design proprietary studies
Customer-Centric Approach
We are committed to providing the best customer experience possible, ensuring our clients receive dedicated support and guidance throughout their engagement with our biomarker discovery and validation services.
Unlock the Power of Biological Data with ions.bio
At ions.bio, we offer a comprehensive, all-in-one solution for biomarker and drug target discovery that revolutionizes your research process. Our integrated approach covers every step of the discovery value chain.
-
Meticulous Study Design and Sample Collection
We collaborate with clinical experts to design proprietary biomarker studies and collect high-quality biosamples at any scale.
-
Cutting-Edge Multi-Omics Data Generation
Our advanced mass spectrometry-based platform transforms your samples into extensive proteomics datasets.
-
Unlock the dark proteome
VeriDyne Profiler extracts all available spectral information ensuring no valuable signal goes unnoticed. With this novel, unbiased approach, you can uncover the unexpected.
Tailored Solutions
End-To-End Service for Biomarker and Drug Target Discovery
From study design and sample sourcing to data production and bioinformatic analysis, we handle it all.
Mass Spectrometry
Expertise
From study design and sample sourcing to data production and bioinformatic analysis, we handle it all.
Bioinformatics
Excellence
From study design and sample sourcing to data production and bioinformatic analysis, we handle it all.
Partner with ions.bio to accelerate your biomarker discovery, enhance your diagnostics coverage, and streamline your drug development pipeline.
Unlock the Full Potential of Discovery Proteomics
Next-generation biomarkers and drug targets, mass spectrometry-based proteomics, lipidomics, and metabolomics. Discover how our biomarker solutions can accelerate your diagnostics and drug development pipeline.